BioCorRx Inc. (OTCMKTS:BICX – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.68 and traded as low as $0.47. BioCorRx shares last traded at $0.47, with a volume of 245 shares.
BioCorRx Stock Performance
The company has a market cap of $4.55 million, a P/E ratio of -1.02 and a beta of 0.59. The business’s fifty day moving average is $0.67 and its 200 day moving average is $0.82.
BioCorRx (OTCMKTS:BICX – Get Free Report) last posted its quarterly earnings results on Wednesday, May 15th. The company reported ($0.14) EPS for the quarter.
About BioCorRx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Stories
- Five stocks we like better than BioCorRx
- What is the S&P 500 and How It is Distinct from Other Indexes
- AbbVie Stock: A Perfect Dip for Investors to Buy
- 3 Best Fintech Stocks for a Portfolio Boost
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Investing in the High PE Growth Stocks
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
